Literature DB >> 16808669

Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues.

K D Joory1, J R Levick, P S Mortimer, D O Bates.   

Abstract

OBJECTIVE: To characterize vascular endothelial growth factor-C (VEGF-C) protein expression in normal human tissues by immunohistochemistry (IHC). VEGF-C is a growth factor for lymphatic endothelial cells. VEGF-C mRNA and protein are expressed in a variety of cancerous tissues, but the localization of VEGF-C protein in many normal human tissues has not been clearly demonstrated to date. We therefore performed an immunohistochemical survey of the distribution of intracellular VEGF-C protein in a range of normal human tissue types.
METHODS: Five microm sections were cut from archived human tissues. Sections were dewaxed, rehydrated, and subjected to microwave pretreatment. They were incubated with VEGF-C antibody before detection with biotinylated secondary antibody using 'Elite' avidin-biotin enzyme complex and diaminobenzidine substrate. The primary antibody recognized the C-terminus of the VEGF-C propeptide that is cleaved before secretion and hence only cellular protein was detected. Negative controls used the same concentration of normal goat IgG.
RESULTS: Staining manifested as small punctate cytoplasmic granules. Strong expression was observed in large intestine epithelium, and mammary duct epithelium, skeletal and cardiac muscle, thyroid, ovary, and the prostate. Weaker expression was also detected in the hepatocytes close to the terminal hepatic venules of the liver, vascular smooth muscle, and placenta. No expression was consistently detected in spleen or thymus.
CONCLUSIONS: Intracellular VEGF-C protein is widely expressed in many normal human adult tissues. Its expression in cancer is not therefore per se indicative of a prolymphangiogenic change. To demonstrate the latter, a quantitative change in expression level is required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808669     DOI: 10.1089/lrb.2006.4.73

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  9 in total

Review 1.  Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant.

Authors:  Masa-Aki Shibata; Jayakrishna Ambati; Eiko Shibata; Katsuhide Yoshidome; Mariko Harada-Shiba
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

2.  Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.

Authors:  Liang-Xi Xie; Tian-Tian Zhai; Li-Ping Yang; Eleanor Yang; Xiao-Hui Zhang; Jiong-Yu Chen; Hao Zhang
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

3.  The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter.

Authors:  Joanna Klubo-Gwiezdzinska; Roman Junik; Ewa Kopczynska; Olga Juraniec; Hanna Kardymowicz
Journal:  Eur J Endocrinol       Date:  2007-10       Impact factor: 6.664

4.  Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.

Authors:  A V Timoshenko; S Rastogi; P K Lala
Journal:  Br J Cancer       Date:  2007-10-02       Impact factor: 7.640

5.  Complex formation of anti-VEGF-C with VEGF-C released during blood coagulation resulted in an artifact in its serum pharmacokinetics.

Authors:  Daniela Bumbaca Yadav; Arthur E Reyes; Priyanka Gupta; Jean-Michel Vernes; Y Gloria Meng; Michelle G Schweiger; Shannon L Stainton; Germaine Fuh; Paul J Fielder; Amrita V Kamath; Ben-Quan Shen
Journal:  Pharmacol Res Perspect       Date:  2020-04

6.  An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood.

Authors:  Shuai Sun; Yang Wang; Tao Ming; Jinping Luo; Yu Xing; Juntao Liu; Ying Xiong; Yuanyuan Ma; Shi Yan; Yue Yang; Xinxia Cai
Journal:  Commun Biol       Date:  2021-01-26

7.  Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells.

Authors:  Silja Raschke; Kristin Eckardt; Kirsten Bjørklund Holven; Jørgen Jensen; Jürgen Eckel
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  Higher vascular endothelial growth factor-C concentration in plasma is associated with increased forearm capillary filtration capacity in breast cancer-related lymphedema.

Authors:  Mads Radmer Jensen; Lene Simonsen; Tonny Karlsmark; Charlotte Lanng; Jens Bülow
Journal:  Physiol Rep       Date:  2015-06

9.  A zebrafish model of inflammatory lymphangiogenesis.

Authors:  Kazuhide S Okuda; June Pauline Misa; Stefan H Oehlers; Christopher J Hall; Felix Ellett; Sultan Alasmari; Graham J Lieschke; Kathryn E Crosier; Philip S Crosier; Jonathan W Astin
Journal:  Biol Open       Date:  2015-09-14       Impact factor: 2.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.